Get the Stockscreener App
3.94
13.75%
0.39
Creative Medical Technology Holdings Inc stock is traded at $3.94, with a volume of 53,865.
It is up +13.75% in the last 24 hours and up +61.52% over the past month.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
See More
Previous Close:
$3.55
Open:
$3.56
24h Volume:
53,865
Relative Volume:
1.20
Market Cap:
$6.20M
Revenue:
$102.80K
Net Income/Loss:
$-5.32M
P/E Ratio:
-1.0368
EPS:
-3.8
Net Cash Flow:
$-5.45M
1W Performance:
+29.01%
1M Performance:
+61.52%
6M Performance:
+33.71%
1Y Performance:
-4.97%
1-Day Range:
$3.55
$4.05
1-Week Range:
$3.10
$4.16
52-Week Range:
$1.957
$10.28
Creative Medical Technology Holdings Inc Stock (CELZ) Company Profile
Name
Creative Medical Technology Holdings Inc
Sector
Industry
Phone
480-399-2822
Address
211 E. OSBORN RD., PHOENIX
Compare CELZ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CELZ
Creative Medical Technology Holdings Inc
|
3.9955 | 6.20M | 102.80K | -5.32M | -5.45M | -3.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.20 | 123.91B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
716.19 | 78.94B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
652.49 | 39.98B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
275.00 | 35.89B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
118.92 | 28.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Creative Medical Technology Holdings Inc Stock (CELZ) Latest News
Creative Medical Technology Holdings (CELZ): AI-Enhanced Stem Cell Therapy for Diabetes - Insider Monkey
12 AI News and Ratings Investors are Keeping Their Eye On - Insider Monkey
Creative Medical Technology Holdings Expands Collaboration with Greenstone Biosciences to Accelerate iPSCelz - EIN News
Creative Medical enhances diabetes treatment with AI tech - Investing.com
Creative Medical Technology Holdings Expands Collaboration with Greenstone Biosciences to Accelerate iPSCelz Pipeline Development - The Manila Times
Breakthrough: AI Accelerates Diabetes Cure Research as Creative Medical Doubles Development Speed - StockTitan
EvokAI Creative Labs Sets Date for Share Consolidation - Yahoo Finance
Clinical Trials News Live Feed - StockTitan
Nisa Investment Advisors LLC Acquires 4,234 Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC) - Defense World
Creative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data from First Cohort in Phase 1/2 Trial of CELZ-201-DDT for Chronic Back Pain - The Manila Times
Creative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data from - EIN News
Revolutionary Stem Cell Therapy Tackles Chronic Back Pain: First Trial Results Unveiled - StockTitan
La Rosa Holdings Corp. Appoints Commercial Real Estate Veteran JM Padron to Lead National Expansion of - EIN News
Odyssey Trust Company Appoints Bryce Szela as Chief Growth Officer - EIN News
Shoals Technologies Group, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and - EIN News
Equinix, Inc. (Nasdaq: EQIX) Investor Alert: Grabar Law Investigates Claims as Securities Fraud Class Action - EIN News
Roivant to Report Financial Results for the Third Quarter Ended December 31, 2024 and Provide Business Update - EIN News
Silvercrest Asset Management Group Inc. Announces Quarterly Dividend - EIN News
Degenerative Disc Disease Treatment Market Size in the 7MM was - openPR
CELZ (Creative Medical Technology Holdings) 3-Year Revenue Growth Rate : -87.20% (As of Sep. 2024) - GuruFocus.com
Bunion correction systems Market Key Players AnalysisStryker - openPR
Creative Global Technology Holdings Ltd's Quiet Period Set To End on January 6th (NASDAQ:CGTL) - MarketBeat
Orange County Bancorp Announces Two-for-One Stock Split - Defense World
Optical Cable Corporation Releases Fourth Quarter and Fiscal Year 2024 Financial Results - Defense World
TechPrecision Corporation Announces Corporate Changes Following Annual Meeting - Defense World
Versus Systems Completes Corporate Continuance and Securities Issuance - Defense World
Creative Medical Technology Holdings, Inc. Reports Amendment to Articles of Incorporation and Voting Results Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) filed a Form 8-K with the Securities and Exchange Commission on December 19, 20 - Defense World
Mergers & Acquisitions Tracker - Plastics News
CELZ stock touches 52-week low at $2.11 amid market challenges - Investing.com India
Creative Global Technology Holdings Ltd trading resumes - Nasdaq
CELZ stock touches 52-week low at $2.21 amid market challenges - Investing.com Australia
CELZ stock touches 52-week low at $2.36 amid market challenges By Investing.com - Investing.com South Africa
CELZ stock touches 52-week low at $2.36 amid market challenges - Investing.com Canada
CELZ (Creative Medical Technology Holdings) 9-Day RSI : 39.05 (As of Nov. 28, 2024) - GuruFocus.com
Creative Global Tech opens at $4.29, IPO priced at $4 per share - Yahoo Finance
Creative Global Technology Holdings Limited Announces Closings of Its Initial Public Offering and the Underwriter’s Over-Allotment Option - Yahoo Finance
Degenerative Disc Disease Market Size in the 7MM was ~USD 3,600 Million in 2023, estimated DelveInsight - openPR
Creative Global Technology Holdings Limited Announces Pricing of Its Initial Public Offering - Yahoo Finance
CELZ (Creative Medical Technology Holdings) 3-Year FCF Grow - GuruFocus.com
CELZ (Creative Medical Technology Holdings) Cash, Cash Equi - GuruFocus.com
CELZ (Creative Medical Technology Holdings) Total Inventories : $0.00 Mil (As of Sep. 2024) - GuruFocus.com
CELZ stock touches 52-week low at $2.49 amid market challenges - Investing.com Australia
CELZ stock touches 52-week low at $2.49 amid market challenges By Investing.com - Investing.com South Africa
Can Creative Global Technology Holdings Limited's (NASDAQ:CGTL) ROE Continue To Surpass The Industry Average? - Yahoo Finance
Equities Analysts Issue Forecasts for CELZ FY2024 Earnings - Defense World
Novozymes A/S (OTCMKTS:NVZMY) & Creative Medical Technology (NASDAQ:CELZ) Head-To-Head Comparison - Defense World
Creative Medical Technology Holdings Inc Stock (CELZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):